



In recent years, the Lesbian Gay Bisexual Transsexual Queer (LGBTQ) community has experienced a number of 
triumphs. From the end of the military’s “Don’t Ask, Don’t Tell” policy to the repeal of the Defense of Marriage 
Act, the political and social landscape in the United States is becoming more inclusive of homosexuality.  While 1
there still remain many discriminatory practices, a particularly egregious one is the U.S. Food and Drug 
Administration’s (FDA) ban on blood donations by men who have sex with men. In addition to being societally 
regressive, this policy frustrates efforts to overcome the nation’s blood shortage. In May 2015, the FDA released a 
draft guidance document suggesting a shift from the existing lifetime ban to a twelve-month deferral period. While 
this is a progressive step in the right direction, the new regulation would require donors to remain celibate for 
twelve months prior to donation, which maintains the categorical association between gay sex, risky sex, and HIV. 
This updated policy is as discriminatory as the lifetime ban and will not significantly increase the number of 
eligible donors. A shift away from a categorical and unnecessary ban towards a systematic and scientifically based 
series of tests and screenings that focus on indicators of risky sex would grow America’s pool of blood donors 
without increasing the risk of transfusion-related transmission of HIV. Support within the academic community 
and populations unaffected by the ban would be effective strategies to challenge and ultimately demand the ban’s 
complete removal. 
Origins of a discriminatory policy 
The FDA implemented its lifetime ban policy in 1983 
as a response to the HIV/AIDS epidemic. During a 
time of crisis, it was intended to exclude populations 
considered to be at high risk: men who have sex with 
men (MSM), women who have sex with MSM, and 
transgender people who were categorized as MSM. 
What began as an emergency measure became an 
entrenched policy, despite advances in HIV 
prevention and detection and an increased awareness 
of HIV risks within these target populations. 
Today, the policy covers MSM and transsexuals who 
have had sex with a man since 1977, as well as any 
women who have had sex with MSM since then. This 
includes individuals in committed and monogamous 
relationships, those who always use condoms, and 
those who have practiced abstinence for decades; the 
ban applies regardless of HIV-negative test results. The 
FDA’s policy is categorical and directly discriminates 
on the basis of sexual orientation.  2
Under the eligibility requirements for blood 
donations, the MSM ban is based on “Lifestyle and 
Life Event” criteria. There are a number of other FDA 
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justifications for ineligibility, such as travel to certain 
countries during an outbreak of an infectious disease, 
receiving an animal organ transplant, or contracting 
hepatitis. The only other lifestyle ban-for-life is 
intravenous, non-prescription drug use.  MSM who 3
practice safe sex in consensual and monogamous 
relationships are considered as high risk for HIV 
transmission as intravenous drug users, while 
heterosexual donors who engage in un-protected sex 
with multiple partners are not. Currently, a straight 
man who has sex with a prostitute is only deferred for 
twelve months, while a gay man who engages in 
healthy, monogamous sex is banned for life.  Under 4
the FDA’s proposed policy change, MSM who remain 
celibate for twelve months may be eligible to donate. 
Although a step in the right direction, this proposal is 
still based in bias and ideology, conflating gay and 
risky sex, rather than focusing exclusively on 
transmission risk factors: men in monogamous same-
sex relationships who test HIV-negative are 
unnecessarily barred from donating by the FDA’s 
current methods. 
Numbers behind the ban 
The latest surveillance data from the US Centers for 
Disease Control indicate that the majority of new HIV 
infections occur in MSM. In 2010, MSM accounted 
for 78% of new infections among American men, and 
63% overall.  5
Still, significant advancements have been made in 
HIV testing since its advent in 1985. Third and fourth 
generation tests can detect HIV antibodies within 
three to four weeks of infection, compared with older 
HIV tests for which the window period was as great as 
three months. ,  RNA tests now detect the virus 6 7
directly rather than through antibodies, further 
narrowing the window period to less than ten days.  8
These improved testing capabilities can mitigate the 
risk of viral transmission despite high infection rates 
among MSM, as every single blood donation is 
currently screened for HIV. MSM who have been 
recently tested can more confidently claim an HIV-
negative status, which poses no donor risk. 
In its appeal to donors, the American Red Cross, 
which supplies approximately 40% of the nation’s 
blood, stresses that “an urgent need for blood and 
platelets” exists, especially since it received 80,000 
fewer donations than expected during the summer of 
2014. ,  While 38% of the population is eligible to 9 10
donate blood, only 10% does.  There is a clear need to 11
increase the donor pool. In a 2010 study conducted by 
the Williams Institute at UCLA School of Law, the 
number of banned donors was calculated to be 
2,603,004.  Were the ban lifted, it would result in an 12
estimated 130,150 additional donors and 219,200 
additional pints of blood.  13
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Due to the number of potential donors that are 
unjustly turned away, the existence of adequate 
screening protocols, and the desire for increased 
donations within the medical community, the current 
restrictions are unconscionable.  Given the 14
importance of blood donations and the ability to more 
effectively screen and test for HIV infections, a serious 
question should be posed to the FDA and the 
scientific community: is it necessary to categorically 
ban MSM from donating blood? 
This is a civil rights and public health 
issue  
In addition to a medical or scientific perspective, the 
FDA’s MSM policy can be viewed through a civil 
rights lens: this is a highly discriminatory policy that 
e x a c e r b at e s t h e s t i g m a s a s s o c i a t e d w i t h 
homosexuality. In the 1980s, the FDA banned all 
Haitian-Americans who had arrived in the country 
after 1977 from donating blood. The agency’s rationale 
was similar to that of the MSM ban: Haiti had a high 
rate of HIV infections and the United States 
government hoped to protect the blood supply. The 
ban was met with huge opposition and was eventually 
removed in 1990.  15
The FDA agreed to a heightened testing protocol 
whereby Haitian-American donors would be tested 
prior to donating, asked modified screening questions, 
and afterwards have their blood donation tested in the 
usual manner. One of the ban’s opposition leaders, Dr. 
Alix Mathieu, remarked that, “this disease is not one 
of races or nationalities…it is one of risky behavior.”  16
This logic equally applies to MSM. The Supreme 
Court of the United States has increasingly used equal 
protection grounds to impose a higher level of 
scrutiny on laws that subject LGBTQ people to 
discrimination.  The FDA has not been able to 17
demonstrate that the ban is rational, necessary, or 
propor t ionate g iven the existence of less 
discriminatory approaches.  
Currently, blood drives leave MSM with two options: 
do not donate (as they currently are instructed), or 
donate and lie about their sexual history (which 
undermines the notion of "coming out”). Both options 
are problematic and promote unhealthy medical 
practices. To enforce a culture in which willing 
individuals may not donate plasma, platelets, or other 
blood products ultimately harms the patients that 
blood centers and healthcare providers exist to serve. 
To incentivize individuals to lie about their sexual 
behavior for the purposes of donating threatens the 
great progress that LGBTQ movements have made in 
recent years. It sends a message to gay men that they 
are still “other” and that at least some part of them is 
unwelcome. As marriage equality continues to be 
constitutionally upheld across the United States, it is 
archaic that gay men and those with whom they have 
had sexual intercourse may not participate in the 
simple but powerful act of donating blood.  18
The current state of the FDA ban 
Although the FDA Advisory Committee on Blood 
Safety and Availability reaffirmed the lifetime ban in 
its December 2013 meeting, the MSM policy went 
under review again in December 2014.  The 19
committee debated a reduction from a lifetime ban to 
a one-year deferral for men who have had sex with 
men within twelve months of attempting to donate, 
although it ultimately voted against the shift. 
In response to the advisory committee’s decision, 80 
members of congress sent a letter to the Department 
of Health and Human Services (HHS), of which the 
FDA is an agency, criticizing a categorical approach 
and urging the department to adopt a risk-based 
policy. The letter concludes by calling on HHS to 
implement an improved policy by the end of 2014.  20
By the end of 2014, the FDA announced it would 
change its MSM policy to a one-year deferral for men 
who have had sexual intercourse with other men 
within the past twelve months. AABB (formerly the 
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American Association of Blood Banks), America’s 
Blood Centers, and the American Red Cross jointly 
supported such a shift, noting that the lifetime ban is 
medically and scientifically unwarranted.  21
In May 2015, the FDA released a draft guidance 
document entitled “Revised Recommendations for 
Reducing the Risk of Human Immunodeficiency 
Virus Transmission by Blood and Blood Products.” 
The document elaborates on the agency’s 2014 
commitment but does little to overcome its historic 
treatment of gay sex as inherently risky sex. In the 
document, the FDA proposes improved Donor 
History Questionnaire questions to screen out 
ineligible donors. The list begins with donors who 
have tested HIV-positive, who have engaged in 
commercial sex, and who have engaged in non-
prescription injection drug use; all of these categories 
would be banned for life. A male donor who has had 
sex with another man within twelve months appears at 
the end of the list, just after donors who have been 
treated for syphilis or gonorrhea and those who have 
received a tattoo or piercing from an unlicensed shop; 
all of these categories, including MSM, would receive 
a twelve month deferral under the proposed policy.  22
The guidance document notes that the male donors 
who report that they are MSM have a lower 
prevalence of HIV infection than the general MSM 
population (.25% as opposed to 11-12%); the FDA 
concedes this suggests “considerable” self-selection by 
MSM individuals who choose to donate.  Despite this 23
evidence that the high rate of HIV among the general 
MSM population does not necessarily translate to a 
high rate of HIV among MSM donors, the FDA’s 
twelve-month deferral does not allow for such self-
selection, instead continuing the categorical 
association between gay sex and risky sex. 
While some groups claim the proposed shift as a 
victory or a step in the right direction, any progress 
that it represents is superficial. The one-year proposal 
is unnecessarily long given that most effective testing 
can be performed within four weeks. More 
importantly, it does nothing to correct the underlying 
stigma and misguided beliefs about gay sex that the 
current ban maintains. This shift excludes an entire 
population of men who could donate and advance 
what should be the agency’s goal: to safely increase the 
nation’s donor pool. 
Under the proposed reform, a man who has frequent, 
protected, and monogamous sex, and who is regularly 
tested, would still be ineligible to donate. The new 
policy would require twelve months of complete 
sexual abstinence in order to donate, which suggests 
that any gay sex is risky sex. It fails to screen 
individual MSM donors for any behavior that may 
make them high risk for HIV, opting instead for the 
same categorical ban. 
The draft guidance document allows for 60 days of 
public comments, after which the FDA will develop 
and release final rules on the matter. 
Alternatives to the ban 
In lieu of a permanent and categorical ban or the 
proposed deferral, the FDA should shift to an "Assess 
and Test” screening system. After assessing the donor’s 
personal sexual practices, a deferral may be given only 
for those in whom a risk of infection has been 
identified, such as individuals who have engaged in 
frequent, unprotected sex with multiple partners since 
their prior HIV test. For this risky group, a short 
period of abstinence may be appropriate to allow for 
reliable test results. For donors who are not high risk, 
the deferral should be eliminated altogether. 
This model can be applied to both homosexual and 
heterosexual donors and would not consider 
monogamous or safe sex to be risky, mirroring the 
current protocol for straight donors.  
As has been the standard since 1985, all blood is tested 
for HIV after donation, so these initial screening 
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questions serve as only the first step in an Assess and 
Test approach.  Under current testing protocol, the 24
risk of transfusion-transmission of HIV is one in two 
million.  25
The United States is not alone in its treatment of 
MSM. South Africa uses a six-month deferral period, 
while the UK, Australia, and Sweden defer for twelve 
months. Canada and New Zealand defer MSM for five 
years.  As with the FDA’s stipulations, these policies 26
require celibacy during the deferral period, 
maintaining illusory associations between HIV and 
gay sex, rather than between HIV and risky sex. Italy, 
however, has adopted an Assess and Test model that 
uses “risk behavior” screening questions and blood 
testing, which it applies to all donors, regardless of 
sexual orientation.  It defers individuals who are 27
flagged by screening, not by lifestyle. Italy has not 
experienced an increase in infected donations since 
implementing this policy.  28
This approach can identify individuals, rather than 
categories, who may present a risk to the blood supply. 
AABB, America’s Blood Centers, and the American 
Red Cross have advocated for the adoption of 
similarly comprehensive approaches.  Unlike the ban 29
on MSM donors or the new deferral, the Assess and 
Test approach uses rational and scientifically based 
deferral periods, applied fairly, to maximize the donor 
pool and minimize risk.  30
Support is essential to ending the ban 
There must be greater awareness among the 
unaffected population in order to end this 
discriminatory policy. To achieve this end, blood 
donation organizers should adopt the following 
practices: 
1. Explain the FDA policies in any marketing 
material that advertises an upcoming blood drive;  
2. Dedicate a page on their website to educate 
visitors about the policies; Inform each blood 
donor of the FDA policies at the time of donation; 
3. Direct donors and the general public to the 
Change.org  petition to repeal the policies and to 31
call on their elected officials to demand improved 
policies by the FDA;  
4. Educate their board of directors, or equivalent 
governing bodies, about the FDA policies; and 
5. In each of the above actions, advocate that simply 
shifting to a categorical deferral policy does little 
t o a d d r e s s t h e b a n’s d i s c r i m i n a t o r y 
underpinnings. 
Generating greater public support and drawing 
attention to the FDA’s inadequate justification of its 
policies are meaningful actions. 
Institutions of higher education across America are 
another important battleground for this issue. For 
many students, college is an opportunity for personal 
and sexual exploration and identification. This can be 
especially true for young, gay men who were not 
raised in accepting environments or who are in the 
process of coming out. To simultaneously receive 
overt messages from the FDA that a homosexual 
lifestyle is somehow perverse can create serious 
emotional and psychological confusion. On the other 
hand, campuses are centers of political and social 
activism where discriminatory practices, once 
acknowledged, can be addressed. Organized protests 
against such policies can provide reassurance for those 
affected. Protests against the treatment of sexual 
violence on college campuses, for example, have both 
made national headlines and received presidential 
attention. Current awareness-raising activities against 
the ban include distribution of information at blood 
drives and the organization of drives where ally 
surrogates can donate in the place of banned 
individuals. 
Opposition to the FDA’s MSM policy should not be 
interpreted as opposition to blood donation itself, 
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which is vital and should be encouraged. It is 
important, however, to demonstrate that donations are 
being made in spite of these policies, and that more 
donors would participate if all policies barring MSM 
donations were lifted. 
Colleges and universities house the next generation of 
American leaders and can play a strong role in 
shaping their social perspectives. Campuses are 
specific, controllable environments in which a strong, 
deliberate movement against the FDA policies could 
take root. Universities are also home to that nation’s 
leading medical researchers, whose expert voices carry 
greater with the FDA and policymakers in general. 
Increased awareness of and organization around the 
FDA’s policy would yield immediate positive health 
effects for affected populations in the form of social 
equity and support, as well as long-term benefits to 
society at large by increasing the donor pool and 
access to blood for those who need it.  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